Risk Factors and Prediction Model of Cancer-associated Venous Thromboembolism
NCT05729464 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 700
Last updated 2023-02-15
Summary
The purpose of this study is to identify risk factors of cancer-associated venous thrombosis and develop a prediction model to assist clinicians in tailoring anticoagulant therapy.
Conditions
- Venous Thromboses
- Neoplasms
Sponsors & Collaborators
-
Yongsheng Jiang
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-23
- Primary Completion
- 2023-07-01
- Completion
- 2023-12-30
Countries
- China
Study Locations
More Related Trials
-
Venous Thromboembolism and Bleeding Risk in Patients With Esophageal Cancer
NCT03646409 ·Status: COMPLETED
-
Prospective Evaluation of the Treatment of Cancer Associated Superficial Venous
NCT07210671 ·Status: RECRUITING
-
Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort Study
NCT05229471 ·Status: UNKNOWN
-
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
NCT03407469 ·Status: RECRUITING
-
Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study
NCT05396157 ·Status: ACTIVE_NOT_RECRUITING
-
Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIO
NCT04846556 ·Status: COMPLETED
-
A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients
NCT02213978 ·Status: COMPLETED
-
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
NCT07215624 ·Status: RECRUITING
-
Anticoagulation Length in Cancer Associated Thrombosis
NCT01817257 ·Status: TERMINATED ·Phase: PHASE2
-
A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient
NCT03114618 ·Status: COMPLETED
-
Understanding Risk Factors Involved in Developing a Second Blood Clot.
NCT00261014 ·Status: UNKNOWN
-
Platelet FcGammaRIIa and Risk of Venous Thromboembolism in Cancer
NCT05240508 ·Status: UNKNOWN
-
VTE and the Related Factors Associated With Higher Rates of PE After a DVT in Southwestern China
NCT05464901 ·Status: COMPLETED
-
Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism
NCT01164046 ·Status: TERMINATED ·Phase: PHASE3
-
Risk Factors for Venous Thromboembolism
NCT00018772 ·Status: COMPLETED
-
Long-term Surveillance of Patients With Venous Thromboembolism: a Nationwide Prospective Cohort Study
NCT06073366 ·Status: COMPLETED
-
Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters
NCT00024297 ·Status: COMPLETED ·Phase: NA
-
Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients
NCT05515549 ·Status: UNKNOWN
-
Effect of Aging on Haemostasis Parameters
NCT00299624 ·Status: COMPLETED
-
Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients
NCT03282643 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prophylactic Anticoagulation for Catheter-related Thrombosis
NCT04256525 ·Status: UNKNOWN ·Phase: PHASE4
-
Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients
NCT00199602 ·Status: COMPLETED ·Phase: PHASE3
-
Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center
NCT02502396 ·Status: COMPLETED
-
Venous Thromboembolism and Bleeding in Hospitalized Medical Patients With Cancer
NCT02407717 ·Status: COMPLETED
-
Implementing VTE Prevention in Ambulatory Cancer Care
NCT07292376 ·Status: ENROLLING_BY_INVITATION ·Phase: NA